Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nihon KohdenTSE:6849 +0.39%68 Gross Margin % is 51.54% as of Mar. 2026, which is 2% above its 10-year median of 50.68. GuruFocus rates TSE:6849 with a GF Score™ of 68/100 and a GF Value™ of 円2,162.06 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 806 Medical Devices & Instruments companies, Nihon Kohden ranks worse than 50.5% on this metric.
The historical rank and industry rank for Nihon Kohden's Gross Margin % or its related term are showing as below:
TSE:6849'
s Gross Margin % Range Over the Past 10 Years
Min: 47.49 Med: 50.68 Max: 53.18
Current: 51.78
During the past 13 years, the highestGross Margin % of Nihon Kohden was 53.18%. The lowest was 47.49%. And the median was 50.68%.
TSE:6849's Gross Margin % is ranked worse than 50.5% of 806
companies
in the Medical Devices & Instruments industry
Industry Median: 52.05
vs TSE:6849: 51.78
Nihon Kohden had a gross margin of 51.54% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Nihon Kohden was -0.10% per year.
Nihon Kohden (TSE:6849) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Nihon Kohden had a gross margin of 51.54% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Nihon Kohden Gross Margin % Related Terms
Nihon Kohden Gross Margin % Historical Data
* Premium members only.
The historical data trend for Nihon Kohden's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6849 vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Nihon Kohden's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nihon Kohden Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nihon Kohden's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Nihon Kohden's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Nihon Kohden (TSE:6849) has a Gross Margin % of 51.54% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Nihon Kohden and its competitors. This is near median its historical median of 50.68. Over the past decade, Nihon Kohden's Gross Margin % has ranged from 47.49 to 53.18. According to the industry distribution chart, Nihon Kohden ranks #407 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 50.5%.
Is Nihon Kohden's Gross Margin % too high?
Nihon Kohden's current Gross Margin % of 51.54% is near median its 10-year median of 50.68. Over the past 10 years, this metric has ranged from a low of 47.49 to a high of 53.18. The Medical Devices & Instruments industry median Gross Margin % is 52.05. Nihon Kohden's value of 51.54% is 1% below this industry median. Based on the distribution chart, Nihon Kohden ranks #407 out of 806 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Nihon Kohden has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nihon Kohden's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nihon Kohden ranks #407 out of 806 companies for Gross Margin %. This places Nihon Kohden in the lower half of its industry. The industry median Gross Margin % is 52.05. Nihon Kohden's value of 51.54% is 1% below this benchmark. Historically, Nihon Kohden's own Gross Margin % has ranged from 47.49 to 53.18 over the past decade. While the company's 10-year median is 50.68 vs. the industry median of 52.05, Nihon Kohden has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.05, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nihon Kohden's current Gross Margin % of 51.54% is 1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Nihon Kohden and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nihon Kohden's current Gross Margin % is 51.54%, which is near median its own 10-year median of 50.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nihon Kohden stock overvalued right now?
Based on GuruFocus' analysis, Nihon Kohden (TSE:6849) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,162.06, compared to a current price of 円1,548.50 — trading 28.4% below its estimated fair value. The current Gross Margin % is 51.54%, which is near median its 10-year median of 50.68 and 1% below the Medical Devices & Instruments industry median of 52.05. Nihon Kohden's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Nihon Kohden (TSE:6849), the current Gross Margin % is 51.54% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nihon Kohden (TSE:6849) Overvalued in 2026?
Based on GuruFocus' analysis, Nihon Kohden stock appears to be undervalued.
The current stock price of 円1,548.50 is trading 28.4% below its estimated GF Value™ of 円2,162.06.
GuruFocus considers Nihon Kohden to be Modestly Undervalued.
Key valuation signals for TSE:6849:
Gross Margin %: 51.54% (near median its 10-year median of 50.68)
GF Value™: 円2,162.06 vs. price of 円1,548.50 (28.4% below fair value)
Industry Position: 1% below the Medical Devices & Instruments median (#407 of 806)
No single metric tells the full story. See the TSE:6849 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nihon Kohden Corp is a Japan-based company engaged in the development, manufacturing, and sale of medical electronic equipment. It offers monitoring and diagnostic equipment such as electroencephalographs, electrocardiographs, and patient monitors, along with related systems and consumables. The company operates as a single business segment and manages its activities comprehensively across three reportable regions: Japan, North America, and Other Regions.
68GF Score
Get the complete analysis for TSE:6849
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6849 has been successfully added to your 
